Pharmacy Podcast Network

This week on TWIRx, we cover the latest headlines shaping pharmacy care, followed by three powerful interviews spotlighting innovation, advocacy, and access. TWIRx News: 13WHAM ABC News: Health Center Turns Away Patients as Medicaid Approval Stalls Pharmacy Services – A troubling look at how bureaucratic delays are cutting off critical access to care for vulnerable populations. Pharmacy Times: Pharmacists' Knowledge Gaps on Kratom: Building Competence for Patient Counseling – Why pharmacists need more education to better guide patients on the risks and benefits of this controversial substance. Pharmacy Times: Navigating Biosimilars and 505(b)(2) Drugs in Oncology – Operational, clinical, and policy strategies to help pharmacists drive adoption and improve cancer care access. Featured Interviews: Ritesh Shah – Founder, Ritesh Shah Charitable Pharmacy Author of Pills to Purpose: From the Pharmacy to the Frontlines: Healing Beyond the Counter, Ritesh shares his journey from personal loss to creating New Jersey's first charitable pharmacy—ensuring life-saving medications reach those most in need with dignity and compassion. Bonnie Bonds – Sykes & Company Live from the 2025 ThoughtSpot Conference, Bonnie brings insights on the financial strategies independent pharmacies need to grow, adapt, and thrive. Srulik Dvorsky – CEO & Co-founder, TailorMed How technology is being used to eliminate financial barriers to care and connect patients with the resources they need to afford treatment. Sponsored by: Sykes & Company – Helping pharmacies succeed with expert accounting, tax, and advisory services.

In the second installment of our 3-part KeySource Series on the Pharmacy Podcast Network, Andrew Crawford, VP of Sales & Marketing at KeySource, joins Todd Eury to explore one of the most urgent priorities for regional and national chain pharmacies — supplier alignment as a driver of strategic growth. With NACDS TSE right around the corner, this conversation takes a hard look at the pressures chains face today — from unpredictable PBM reimbursements and restrictive PVA contracts to the operational ripple effects of even a single NDC disruption. At chain scale, where central fill and automation keep thousands of prescriptions moving daily, stability, flexibility, and strategic control are non-negotiable. In this episode, we cover: The State of Chains: How PBM volatility, slim PVA margins, and supply continuity challenges are reshaping priorities. The Shift Toward Supplier Alignment: Why leading chains are moving beyond rigid structures to build strategic, responsive partnerships. How KeySource Supports Chain Growth: From NDC continuity to opportunistic buys, primary award support, and autonomy beyond PVA constraints. Strategic Support Beyond the Product: The downstream impact of supply instability — and how proactive supplier partnerships mitigate risk. Looking Ahead to NACDS TSE: How to turn supplier relationships into a competitive edge. Whether you manage a regional chain or lead procurement for a national brand, this episode unpacks the supplier strategies that can protect your operations, enable growth, and strengthen your competitive position in a volatile market.

Join experts in obesity, Robert Kushner, MD, Angela Golden, DNP, FNP-C, FAANP, FOMA, FTOS, and Cally Smith, APRN, FNP-C, as they discuss obesity from a patient's perspective. Speakers:  -          Bob Kushner, MD  -          Angie Golden, DNP, FNP-C, FAANP, FOMA, FTOS -          Cally Smith, APRN, FNP-C

In this episode of Pharmacy Crossroads, Bruce Kneeland shares examples of simple, effective and affordable marketing, advertising and management tools he has seen others use.  The real lesson, according to Kneeland, is that marketing is essential to a modern pharmacies success. But he also feels that not all marketing need involve buying ads or spending large sums of money.  Grass Roots Marketing, that is getting out, being creative and responding to local opportunities is a great way to grow.

Guests:

Introducing Melissa Smith, PharmD, CPH, CPGx, Founder of Florida PGX Consulting, and the new host of the Precision Health and PGX Podcast! Dr. Melissa is joined by her guests Dr. Jamie Wilkey & Dr. Jackie Boyle to discuss their introduction to precision medicine in PGX, as well as their friendship that encouraged it!

In this episode, we break down the smart ways to integrate AI into your healthcare marketing strategy—and the pitfalls to avoid. From simplifying complex healthcare concepts for patient-friendly content to understanding the risks of misinformation and non-compliance with healthcare guidelines, we cover what every healthcare owner and their marketer needs to know when working with AI. Tune in for practical insights, real-world examples, and a clear path to using AI responsibly and effectively.

In this episode of TWIRx, we explore how pharmacy accounting has evolved from basic bookkeeping into a strategic business development tool powered by artificial intelligence, data analytics, and specialized accounting expertise. Pharmacy owner & PPN Podcast Host Dr. Adam Robinson and Titan Accounting's team members Nicholas Caltabiano & Jordan Pridemore dig into what modern pharmacy owners must understand to stay financially healthy and competitive in today's complex marketplace. Learn more by going to Titan's website: https://titanswork.com/home    Next, we talk with CEO & Founder of RxInsider, Gregory Cianfarani RPh, sharing the Colleges of Pharmacy Report 2025. RXinsider's Market Intelligence Group produces weekly newsletters, market reports, and specialty INTEL Reports covering various segments of the pharmacy ecosystem—including an exclusive report on colleges of pharmacy.    Find the full report here:  https://ebook.rxinsider.com/flip-book/37174/2065397   Beyond the Ledger: How AI & Accounting Impacts Pharmacy Growth | TWIRx

In this episode, Dr. Ryan Paul Liabenow sits down with Kaleb Graves to explore the complex role of psychedelics in mental health treatment and addiction recovery. Together, they unpack the stigmas surrounding these substances. From the "cure all" claims to discrediting users who have become advocates. This conversation dives into harm reduction, spiritual framing, and the need for nuance in an increasingly polarized conversation about psychedelic medicine.

This special episode of the NASP podcast features MedAdvisor leaders Megan Butterfield, Vice President of Network Solutions and Vinod Subramanian, Chief Operating and AI Officer in conversation with Shelia Arquette, President & CEO of NASP, as part of a collaborative spotlight for MedAdvisor Solutions' Beyond the Script podcast series. They discuss how AI, when applied thoughtfully, can help us not only meet the demands of patients' increasingly intricate care journeys, but do so in a way that enhances the human experience, facilitating personalized engagement, real-time education, empathy and trust, while keeping what's special about specialty pharmacy. 

How can we prevent our older adults with prediabetes from developing diabetes?  Susan is a board certified health and wellness coach.  She is a certified with the CDC diabetes prevention program and owner of Weighting4You.  She will walk us through the use of continuous glucose monitors (CGMs) to assist with lowering HgbA1c, counseling tips for patients on GLP-1 RAs, and more.  I hope you enjoy our conversation.   The Geriatric Pharmacy Focus podcast is for general informational purposes only and does not constitute the practice of medicine, nursing or other professional health care services, including the giving of medical advice, and no doctor/patient relationship is formed. The use of information on this podcast or materials linked from this podcast is at the user's own risk. The content of this podcast is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Users should not disregard or delay in obtaining medical advice for any medical condition they may have and should seek the assistance of their health care professionals for any such conditions. Connect with Tamara here:  www.linkedin.com/in/tamara-ruggles-491882251 www.thedeprescribingclinic.com Connect with Susan here:linkedin.com/in/susanward https://weighting4you.com/

Welcome to PART ONE of our Three Part series covering the McKesson IdeaShare Conference in Nashville TN.   Today's interviews features: Ashton Maaraba President of IPC Digital Health Independent Pharmacy Cooperative (IPC)   U.S. Representative Buddy Carter Georgia State Congress   Greg Reybold Vice President of Healthcare Policy & General Counsel APCI, Inc.   Christopher Darling Darling Apothecary LLC   Chuck Schneider Lifecykel

In this episode of Theory & Insights, we bring together two thought leaders at the intersection of healthcare innovation and pharmaceutical manufacturing — John Nosta, renowned AI and technology theorist and founder of NostaLab, and Stephen Beckman, CEO of YARAL Pharma, a rising force in U.S. generics. Together, they dive into the evolving impact of Artificial Intelligence (AI) and Large Language Models (LLMs) on pharmaceutical manufacturing. The discussion covers the promise and peril of AI in reshaping everything from R&D to regulatory pathways, as well as the ethics, economics, and operational shifts that could redefine the industry in the next decade. This is a must-listen for pharma execs, digital health strategists, and technology innovators looking to understand what's next.

In this episode, YARAL Pharma CEO, Stephen Beckman joins clinical sports pharmacist Jessica Beal, PharmD. to discuss an important topic for athletes and active individuals – the role topical NSAID patches can play in acute pain management. Listeners can visit www.YARALPharma.com to learn more about the company and its products or connect on LinkedIn.    Diclofenac Epolamine Topical System 1.3%    Diclofenac Epolamine Topical System 1.3% is a nonsteroidal anti-inflammatory drug (NSAID) used for treating acute pain from minor strains, sprains, and bruises in adults and children aged 6 and older.     Serious side effects may include increased risk of cardiovascular and gastrointestinal (GI) events. NSAIDs can raise the risk of heart attack, stroke, gastrointestinal bleeding, ulceration, and perforation of the stomach and intestines, which can be fatal. The risk for serious cardiovascular events may occur early in treatment and may increase with duration of use. Elderly patients and those with a history of peptic ulcer disease or GI bleeding are at higher risk for serious GI events.    Do not use in patients who are allergic to diclofenac or any of its ingredients, or have a history of asthma, urticaria, or other allergic-type reactions after taking aspirin or other NSAIDs. Do not use in the setting of coronary artery bypass graft surgery. Avoid use on broken skin. Discontinue immediately if signs of hypersensitivity occur.      Patients should be informed about the warning signs and symptoms of liver problems. Discontinue use if abnormal liver tests persist or worsen or if signs of liver disease develop. Avoid using Diclofenac Epolamine Topical System 1.3% in patients with severe heart failure unless the benefits are expected to outweigh the risks.    The most common side effects include itching, nausea, and headache. Patients should stop use and consult their doctor at the first sign of skin rash or other signs of sensitivity.    Patients should ask their doctor if Diclofenac Epolamine Topical System 1.3% is right for them. For more information and Full Prescribing Information including Boxed Warning and Important Safety Information, visit www.yaralpharma.com   Dr. Beal is not affiliated with YARAL Pharma. All views and opinions regarding pain management are solely her own and are not attributable to YARAL or the Pharmacy Podcast Network. 

Tune in to a multi-episode recap of the Retail Business Conference with returning special guest host Adam Robinson, Owner of Save-Rite Drugs in Lexington, Kentucky. Receive the highlights from Cardinal Health customers, employees, services and more at RBC 2025. This episode's topic is navigating Part B Biling for CGM Devices. This discussion will dive into the nuances that make Medicare billing a challenge for pharmacies and ways Cardinal may be able to help.

Welcome to the first episode of Supply, Trust, and the Business of Pharmacy hosted by Andrew Crawford.

This Week in Pharmacy – July 25, 2025 Episode Summary: This week, we spotlight a growing but often overlooked threat to patient safety and healthcare integrity: the diversion of non-controlled substances. While most discussions around drug diversion focus on controlled substances, a troubling pattern has emerged involving medications not classified as controlled—yet still susceptible to misuse, theft, and exploitation. Our guest is Alan McGill, a Senior Supervisory Special Agent with over 30 years of investigative experience, including 23 years in law enforcement. Agent McGill is a nationally recognized expert on drug diversion, having trained thousands across healthcare and law enforcement. In this episode, he sheds light on how non-controlled substances are being diverted within healthcare settings, why it's happening more frequently, and what pharmacies and healthcare systems must do to detect and prevent it. We explore: Common myths about non-controlled medications and diversion risk Real-world cases and investigative red flags Compliance blind spots in retail and institutional pharmacy settings Actionable recommendations for pharmacists, techs, and healthcare leadership The role of education, oversight, and reporting in stopping this silent epidemic Plus, Agent McGill discusses his work with NASCSA and offers insight into how national policy and local practices can align to protect both patients and professionals. Don't miss this essential conversation for pharmacy leaders, compliance officers, and healthcare professionals committed to medication safety.

The show discussions are Modern Medical Mafia and Patient Protector - two projects to help expose PBMs. We discussed ways independent pharmacy owners can get involved in local legislation and patient education about PBMs and how they impact pharmacies. 

Sponsored by Eyecon by RxSafe Guests: Joe Moose, PharmD (Moose Pharmacy) & Joe Williams, RPh (APEX Pharmacy Consulting) Podcast Series: LTC Pharmacy at Home: Redefining Independent Pharmacy Growth Episode Summary: In Part 3 of our Eyecon by RxSafe-sponsored series, we dive deep into how independently owned pharmacies can scale their business and impact patient lives by expanding into Long-Term Care at Home (LTC-at-Home). Joined by industry leaders Joe Moose of Moose Pharmacy and Joe Williams of APEX Pharmacy Consulting, we break down the Top 5 ways community pharmacies can lead the LTC-at-Home movement — offering actionable strategies to support medically complex patients, differentiate services, and integrate more deeply into the care team. This episode delivers a blueprint for pharmacies ready to go beyond traditional retail and build recurring revenue with purpose-driven patient care.

Welcome to the Opioidology podcast series! First up to bat, ‘Our Opioid Story”. You've heard, seen, and most likely experienced many facets of the Opioid Crisis. The doom, the gloom, and perhaps a pinch of hope. The kidney punches to us healthcare professionals continue, while tightening the constraints on our patients in pain and in recovery like never before, all while more and more heartbeats are continually lost. But how did we really get here?  Listen in to this Pain Pod episode for an unbiased, in your face, here's how it is approach to explaining the timeline of the opioid crisis, our opioid story. Come one, come all, to the Pain Pod!!! Pain Guy • www.painguy.us

Being a pharmacist is exciting–as long as you're willing to try new things. These are wise words from my returning guest on today's podcast, who has been paving the way for integrative pharmacy. Dr. Swathi Varanasi is an award-winning pharmacist passionate about the intersection of personalized medicine, patient outcomes, and innovation. With experience spanning patient care, biotech, research, academia, and consumer product goods, Dr. Swathi has paved the way for healthcare professionals to pursue non-traditional career paths through creating postdoctoral training programs, industry internships, and online educational programs. She co-founded and serves as Chief Scientific Officer of the Life Sciences Division at Element Apothec, and serves as a Principal Investigator at contract research organization, Citruslabs. Dr. Swathi received her Doctor of Pharmacy (PharmD) at the Medical University of South Carolina and Bachelor of Arts (BA) at Carleton College. She was the first-ever pharmacist in the United States with formal residency training to specialize in integrative medicine and preventative health. She also completed a postdoctoral fellowship in Medical Affairs in biotech and has training in nutrition from Cornell University. Dr. Swathi has served as faculty and guest lectures at colleges and universities across the country. She is an advisor and consultant for a number of for-profit and nonprofit organizations aiming to make the world a healthier place for us to live–and thrive. She has been published in peer-reviewed academic journals and featured in Yahoo, mindbodygreen, Well+Good, Entrepreneur, Forbes Health, and more. In 2023, Dr. Swathi was voted one of the 50 Most Influential Leaders in Pharmacy. Connect with Dr. Swathi via: Email: swathimvaranasi@gmail.com  FB: Doctor Swathi  IG: @drswathivaranasi Linked In:Dr. Swathi Varanasi  Check out our earlier episode here: https://www.marinabuksov.com/s03e03-paving-the-unconventional-path-with-integrative-pharmacist-dr-swathi-varanasi/ 

This week's TWIRx puts the pedal to the metal—literally. Host Todd Eury dives into the surprising parallels between racing 150+ MPH and building a pharmacy business from the ground up. Special guest Charles Hoopes, co-owner of S&H Motorsports, joins the show alongside Stephen Beckman, CEO of YARAL Pharma, to preview the upcoming “Geezer Race” on Saturday, July 19th, sponsored by YARAL. Charles shares the intense highs and lows of becoming a drag racing team owner—from financial risk to the emotional rollercoaster of chasing a dream. His story mirrors the grit and resilience required to own and operate an independent pharmacy today.

In this episode of the NASP Podcast, Sheila Arquette, President & CEO of NASP, speaks with Jonathan L. Swichar, Partner and Chair of the Duane Morris Pharmacy Litigation Group, and Bradley A. Wasser, Partner, Duane Morris, LLP. They discuss the dramatically shifting legal and regulatory landscape facing non-PBM affiliated specialty pharmacies and recent federal efforts that are reshaping the ways specialty pharmacies do business.

In this episode, we're joined by Nathan Taylor, VP of Sales & Business Development at SureCost, to unpack the real impact of “convenience” in pharmacy purchasing—and why relying solely on a single vendor could be costing your pharmacy more than you realize. We explore the hidden risks of vendor-controlled pricing, delayed reporting, procurement errors, and the operational strain of drug shortages. Nathan shares how SureCost empowers pharmacies to regain control with real-time data, contract compliance tools, and integrated vendor comparisons—all within a unified purchasing platform.

In this essential conversation, New Jersey State Senator Vin Gopal joins the Pharmacy Podcast Network to break down the urgent fight for Pharmacy Benefit Manager (PBM) reform. Senator Gopal shares insight into how states are pushing back against unfair PBM practices—and what federal momentum means for pharmacists nationwide. We also explore how technology platforms like PrimeRx can help independent pharmacies adapt, protect margins, and stay audit-ready in a fast-changing regulatory landscape. This episode is a must-listen for pharmacy owners, policy advocates, and industry stakeholders who want to stay ahead of reform and safeguard the future of community pharmacy.

In this episode of TWIRx, we break down H.R. 1 — The One Big Beautiful Bill Act — and what it could mean for the future of pharmacy in America. From PBM reform and drug pricing transparency to Medicaid restructuring and NADAC expansion, this bill carries enormous implications for community pharmacy, behavioral health services, and specialty care. Joining us to unpack the real-world impact of this legislation are two influential voices in the pharmacy space: Ryan Paul Liabenow, CEO of Mango Health, a behavioral health specialty pharmacy redefining care models for patients with complex mental health needs. Ryan shares insight into how fairer reimbursement models and drug cost transparency could unlock new clinical and economic opportunities for pharmacies serving vulnerable populations. Nicolle McClure, President & CEO of GRx Marketing, marks her 15-year milestone as one of the most respected voices in independent pharmacy marketing. Nicolle discusses how pharmacy communication must evolve in this new legislative landscape—and why strategic messaging, patient education, and digital storytelling are now more critical than ever. We also explore the potential challenges H.R. 1 brings, including the administrative burden of NADAC compliance and the tension between progressive pharmacy reforms and simultaneous Medicaid restrictions. Will increased oversight and transparency finally tip the scale in favor of independent pharmacies—or will coverage erosion undercut the gains? Don't miss this timely discussion on what may be the most consequential pharmacy bill in decades—and how forward-thinking pharmacy leaders are preparing for what's next.   sponsored by IPCRx.com

In this episode of RxGenius, Ryan Paul Liabenow sits down with Jason Torress with Sana Capital.

Here are the TOP 5 ways independently owned pharmacies can build their businesses through the expansion of "LTC Pharmacy at Home" services   1. Target Medically Complex Patients Stand out with personalized medication management Partner with home health, geriatricians, and specialists Offer in-home or telehealth MTM services Position pharmacists as key care team members 2. Offer Specialized Packaging & Delivery Boost adherence with simple, consistent solutions Use blister packs or multi-dose packaging Provide branded, scheduled home delivery Sync refills to reduce confusion 3. Provide 24/7 Clinical Support Be there when patients need you most Set up pharmacist-on-call or live chat Offer after-hours medication delivery Promote to referring providers 4. Build Referral Networks Earn trust as a reliable LTC-at-home partner Create materials for providers and agencies Attend care coordination meetings Host educational sessions for partners 5. Promote Cost & Outcome Benefits Show your impact on care and cost Share data on reduced readmissions and errors Highlight prevention of missed doses Explore payer partnerships and reimbursements

Today I am sharing an important conversation with one of my primary herbal teachers, about the micro and macro views of health and healing. Modern life too often disassociates us from our innate identity and relationship with our greater ecosystem, biome, and planet. Herbal medicine, when practiced deeply and mindfully, goes beyond a simplistic replacement of conventional medicine with "natural" remedies, but moves us sometimes subtly and sometimes profoundly toward a recovery of our biological identities. The human body has the innate power to heal itself. Without this power to self heal, even the most advanced medications and surgical procedures would ultimately fail. The role of the herbalist in the healing process is to consider the client as a whole person, and to consult her/him/them concerning changes in lifestyle, diet, herbs, and supplementation in order to foster an increased state of balance and health - thus maximizing the body's self healing capabilities. Herbal medicine is not only the people's medicine, it is the planet's medicine. While we celebrate the increasing popularity of using herbs, we need to ensure herbal traditions remain true to our roots and accessible to all. Richard Mandelbaum RH is a clinical herbalist with a private practice, offering personalized health consultations, online and in person in the southern Catskills, NY. Richard has been an avid student of our native flora for close to forty years, and in addition to seeing clients he teaches classes in clinical herbal medicine, field botany, and phytochemistry. He is a co-founder and core instructor at the ArborVitae School of Traditional Herbalism and is on the faculty at David Winston's Center for Herbal Studies and the Won Institute of Graduate Studies. He has been a Registered Herbalist since 2003 and was a member of the American Herbalists Guild board of directors from 2012 to 2018. Richard lives with his wife Gabrielle and his daughter Rose in their straw bale home in Forestburgh, NY. You can learn more about Richard, including articles, podcast interviews, etc. at Richard Mandelbaum RH Connect with Richard via: Email: richard@arborvitaeny.com  Website: Richard Mandelbaum RH

Join us for a deep dive into the IVF patient journey with special guest Kelly Gonda, a passionate pharmacist and Fertility Nurse Practitioner. In this episode, we explore how pharmacists can improve safety, outcomes, and access to fertility treatment by understanding the science of in vitro fertilization and the medications involved.

This Week in Pharmacy – June 27, 2025 Episode Title: “Going on the Offensive to Protect Public Health”

In the premiere episode of The Executive Dose, host Stephen Beckman—CEO of YARAL Pharma—sits down with Nicholas Hart, CEO of IBSA USA, for a timely and insightful conversation on the forces shaping the pharmaceutical industry in 2025. From supply chain disruption and regulatory pressure to innovation in both branded and generic sectors, these two leaders explore how today's pharma CEOs are steering through uncertainty and preparing for the next wave of transformation. Key Topics Discussed: Introduction to The Executive Dose and its mission to spotlight leadership perspectives in pharma. Stephen Beckman shares his journey leading YARAL Pharma, the U.S.-based generics subsidiary of global healthcare leader IBSA Group.   Hart, CEO of IBSA USA, joins to discuss market dynamics from the branded side of the business. Why this conversation matters in today's complex and rapidly evolving healthcare environment. What's shaping pharma today—global uncertainty, supply chain instability, and shifting regulatory frameworks. The evolving relationship between branded and generic innovation: where the most impact is happening. How executives are leading through volatility while maintaining patient-centric growth strategies. The importance of resilient leadership, cross-sector collaboration, and long-term portfolio planning. Emphasis on strategic alignment, regulatory agility, and mission-driven innovation. Predictions for the next 3–5 years: What will define success in pharma? How R&D, commercialization, and market access are being reimagined. Advice for rising leaders in the pharmaceutical space: Be bold, stay grounded, and lead with purpose. Episode Takeaways: Innovation isn't just about products—it's about mindset, agility, and leadership. Both branded and generic companies have a role in shaping the future of accessible, high-quality care. Strategic foresight and collaboration will define the next era of pharmaceutical growth.

To lease or not to lease…or to purchase?  When it comes to getting a new vehicle for the pharmacy, one of the most common questions we get asked from owners is “should I lease or should I purchase a vehicle?”  In this episode of Master The Margin, Scotty Sykes, CPA, CFP and Kathy Blanchard, Senior Pharmacy Accountant break down this question and what it means for your tax strategy including: - Why leasing might limit your tax strategy - How purchasing a vehicle can unlock large write-offs - Importance of mileage logs and business-use documentation - How a separate delivery LLC could protect your pharmacy from liability Check out the full episode with bonus insights: https://masterthemargin.substack.com/ Schedule an Rx Assessment: https://www.sykes-cpa.com/rx-assessment-service/  More resources about this topic: Podcast - One Big, Beautiful Bill: What the New Tax Proposal Means for Pharmacies: https://www.youtube.com/watch?v=99jnN08jGUo Blog – Tax-smart Depreciation on Pharmacy Buildings and Equipment: https://www.sykes-cpa.com/tax-smart-depreciation-on-pharmacy-buildings-and-equipment/

With 20 years of experience spanning top pediatric hospitals, cutting-edge research, and digital health leadership, Sharmeen brings unmatched insight into what it takes to personalize care at scale—especially for our smallest, most complex patients. From gene-guided dosing to scaling PGx programs in hospital systems, we discuss: Why a "one-size-fits-all" model doesn't work in pediatrics How PGx can reduce the "trial-and-error" of ADHD, anxiety, and pain meds What it means to operationalize precision medicine in hospitals and clinics Her career journey—from the bedside to boardrooms and biotech The intersection of technology, pharmacy, and compassionate care Plus, don't miss Sharmeen's thoughts on: The future of pediatric PGx What excites her about working with organizations like CPIC, STRIPE, and PPA

The field of Holistic Dentistry has fascinated me ever since I learned about the work of Dr. Weston A. Price and his research into the diets that support healthy teeth and jaw development. Join me in this fascinating conversation with a renowned expert in this field. Dr. Patel's Green Dentistry practice focuses on the patient, first and foremost. From the spa-like comforts to high-tech, non-invasive treatments, every aspect of her practice is thoughtfully designed and focused on cosmetics, comfort, and your lifelong health. Dr. Nammy Patel is a graduate of the University of California's School of Dentistry and a trailblazer in holistic, eco-friendly dental care. She is the founder of Green Dentistry and a passionate advocate for merging Ayurvedic principles with cutting-edge technology to promote total health and well-being. As a published author and respected leader in her field, Dr. Patel educates dentists and hygienists globally, emphasizing the powerful connection between oral health and overall vitality. Her passion extends beyond the dental chair into meaningful global and community initiatives. Dr. Patel leads a nonprofit that supports over 3,000 villages annually and works toward her mission of preventing oral cancer in one million people in India. She is actively involved with the American India Foundation and supports various humanitarian causes, believing deeply in using her platform for the greater good. Born in Dharotha, India, and immigrating to the U.S. at age five, Dr. Patel brings a global perspective to everything she does. She has built one of the most advanced, spa-like dental practices, offering patients both exceptional care and a nurturing environment. Her commitment to health, sustainability, and social impact continues to inspire change across the dental industry and beyond. Connect with Dr. Nammy via: Email: nammypatel@gmail.com  Website: drnammypatel.com, GreenDentistry.com FB: Dr. Nammy Patel  IG: @drnammypatel X: @DrNammyPatel Linked In: Nammy Patel

In this relaunch of the PBM Reform Podcast, Greg Reybold returns with a powerful and timely conversation exploring how concentrated economic power—particularly in the form of Pharmacy Benefit Managers (PBMs)—is undermining fair access to prescription medications, driving up drug costs, and crushing independent pharmacies. Greg is joined by Emma Freer, Senior Policy Analyst with the American Economic Liberties Project, a national non-profit and non-partisan organization dedicated to dismantling monopolistic control across critical sectors—including healthcare. Together, they dig deep into how PBMs serve as gatekeepers in the drug supply chain, extracting value at the expense of patients and providers, and how policy reform is urgently needed. Emma outlines how Economic Liberties is driving a new wave of anti-monopoly policy momentum in healthcare by advocating for stronger antitrust enforcement, corporate accountability, and legislative transparency. She highlights how concentrated PBM power not only threatens economic fairness but undermines public health outcomes.

In this high-impact episode, Todd Eury leads a grounded and insightful discussion about smarter pharmacy purchasing in one of the most challenging business climates pharmacy has ever faced. Joined by Josh Miller of HAC Pharmacies and SureCost founder Calvin Hunsicker, the conversation reveals both the pain points and the real-world solutions driving meaningful change for pharmacy leaders. Josh shares how managing procurement for 24 pharmacy locations used to mean hours of manual price comparisons and reactive decisions. That changed when his team adopted SureCost—resulting in over $200,000 in savings every four months. Josh walks listeners through the implementation journey, staff adoption, and the purchasing tools that now empower his team to make confident, data-driven decisions. Calvin brings industry-wide context with findings from the 2025 Smarter Purchasing Report, highlighting stubborn inefficiencies in pharmacy procurement and why so many organizations still rely on outdated processes. He unpacks key data trends, the surprising insights from this year's report, and what leaders can take away to begin transforming their own operations. This episode is more than a success story—it's a strategic playbook for pharmacy operators who are ready to lead through disruption, adapt to pricing volatility, and take back control of their margins.

In this thought-provoking episode of RxGenius, host Dr. Ryan Paul Liabenow sits down with Nadia Archambault, PharmD—a pharmacist, certified sexual health therapist, and trailblazing entrepreneur—to unpack the often-misunderstood topic of sexual health. Together, they explore why sexual health is far more than just STI prevention and reproductive function. The conversation dives deep into the psychological, emotional, and relational components of sexuality, highlighting how pharmacists and healthcare professionals can better recognize and support the full spectrum of patient needs. Nadia shares her perspective on common misconceptions, the stigma surrounding sexual well-being, and the importance of approaching patient care with sensitivity, curiosity, and respect for diverse experiences. This episode challenges traditional views and emphasizes the essential role sexual health plays in overall well-being. Key Topics Covered: Redefining sexual health beyond disease prevention The mental and emotional dimensions of sexual well-being Pharmacists' roles in normalizing and supporting sexual health conversations Addressing stigma and tailoring care to diverse identities and needs Nadia's journey from pharmacist to sexual health advocate and entrepreneur Tune in to RxGenius for an open, insightful dialogue that will reshape how you think about sexual health in pharmacy and patient care.

Today I got to have an amazing conversation that busts myths and makes the road to recovery seem simple and in one's reach. My guest's message is that you can solve even complex health problems with a systematic and proven step by step approach. Mel Hopper Koppelman, Program Director at Synthesis Health Lab, is the go-to expert for people who've "tried everything" to heal their chronic illness but keep hitting dead ends. By guiding her patients through a systematic 5 Stage Process, she helps patients achieve a 50%+ reduction in symptoms without endless supplements or constant lab testing. With two master's degrees and 15 years of clinical experience, Mel has pioneered a revolutionary approach that combines Chinese medicine, functional medicine, and developmental neurology. Her methods have helped thousands of patients recover from conditions like chronic fatigue, autoimmune disorders, and fibromyalgia when conventional and functional medicine failed. In a world where chronic illness is skyrocketing and patients spend thousands on supplements and lab tests without getting better, Mel is passionate about providing relief. Instead of chasing symptoms and over-focusing on lab markers, she helps people understand the first principles of healing and repair their nervous system's foundation. Her mission is transforming how we approach chronic illness by bridging the gap between ancient wisdom and modern neuroscience. Connect with Mel via: Email: melhk@fastmail.com  Website: https://synthesishealth.co/shl FB: Mel Hopper Koppelman IG: @synthesishealth.co Linked In: Mel Hopper Koppelman Listeners can apply to be a free Guest in the Synthesis Health Solutions and Support Group. They can find the application at https://synthesishealth.co/shl

In this episode of the NASP Podcast, Sheila Arquette, President & CEO  of NASP, speaks with Dr Andrew Lindsley, US Medical Director at  Amgen and Dr Ash Davé, Director, Medical Value and Population  Health at Amgen, to discuss TEZSPIRE® (tezepelumab-ekko). 

Check out the full episode with bonus insights: https://masterthemargin.substack.com/p/one-big-beautiful-bill-what-the-new Schedule an Rx Assessment: https://www.sykes-cpa.com/rx-assessment-service/ More resources about this topic: Podcast - Master The Margin: 2025 Tax Outlook: https://www.sykes-cpa.com/tax-cuts-and-jobs-act-2025-outlook/ Webinar - Tax Cuts and Jobs Act of 2017: Pharmacy Impact and §199A: https://www.sykes-cpa.com/tax-cuts-and-jobs-act-of-2017-pharmacy-impact-and-%c2%a7199a/ Blog – Tax-smart Depreciation on Pharmacy Buildings and Equipment: https://www.sykes-cpa.com/tax-smart-depreciation-on-pharmacy-buildings-and-equipment/ Blog – Maximize Pharmacy State and Local Tax Deductions (SALT): https://www.sykes-cpa.com/maximize-pharmacy-state-and-local-tax-deductions-salt/  

Dr. William Soliman is the founder and CEO of the Accreditation Council for Medical Affairs (ACMA). The ACMA is America's leader in life sciences accreditation, certification & training.  Soliman is a former pharmaceutical executive who worked in leadership roles at Merck, Abbvie, Gilead and more. He is considered a pharma industry futurist and has been featured on NewsNation, Fox News, Newsmax, Forbes, Al Jazeera, Yahoo Business TV, ABC News Radio & more. The ACMA established the first ever certification standards in the United States and stands as a benchmark of excellence for prior authorization professionals, reimbursement professionals, pharmaceutical sales professionals, medical science liaisons and medical affairs professionals.  Dr. Soliman received his PhD from Columbia University & his BA from New York University.

In this special episode of FrameworkFocus, we're getting you ready for the 2025 FrameworkLTC Innovation Conference—Where LTC Pharmacy Connects. You might remember it as our “User Conference,” but we've refreshed the name to better reflect where we're headed. This event has always been about more than just software; it's about accelerating innovation, sharing ideas, and shaping the future of Long-Term Care Pharmacy. Tune in as we highlight what's new for this year, what attendees can expect, and why this event continues to be a must-attend gathering. Plus, hear from Matthew Gilbert, VP of Business Transformation and Major Accounts at RxSafe, Diamond sponsor this year, who shares insights from a vendor perspective and discusses why RxSafe is excited to participate in this year's conference.

Join us as we celebrate 10 years of biosimilars. In this episode of The Counter Talk™ Podcast host Jason Callori speaks with Dracey Poore, Director of Biosimilars at Cardinal Halth to discuss the evolution of biosimilars and their impact on the healthcare landscape. Dracey shares valuable information on it's importance within the market and role of pharmacists. Click here to download the report and learn more. https://www.cardinalhealth.com/en/product-solutions/pharmaceutical-products/biosimilars/biosimilars-report.html

Join obesity experts, Dr Robert Kushner, Rameck Hunt, and Michael Knight, as they discuss the impact of social determinants of health (SDOH) on patients with obesity. • Robert Kushner, MD • Rameck Hunt, MD • Michael Knight, MD This podcast is sponsored by Novo Nordisk and is intended for healthcare professionals.  

Panelists: Scott Wittnebel – Director of Pharmacy Services, IPC Mark Kinney – Executive Vice President of Government Relations, IPC Sam Pomeroy – Director of Pharmacy Services and Specialty Programs, IPC Nick Secrest – Vice President of Member Performance, IPC​ Visit www.ipcrx.com to learn more about IPC's services

In this episode of the PrimeRx Podcast, David Kirkus breaks down one of the most pressing challenges facing today's pharmacy industry—pharmaceutical tariffs. With increasing trade tensions and new policies taking shape, pharmacies across the country are bracing for the potential ripple effects on drug pricing, supply chain stability, and patient access. David unpacks how tariffs on imported Active Pharmaceutical Ingredients (APIs) and finished medications—especially from countries like China and India—are creating vulnerabilities in a system already strained by global disruptions. Listeners will gain a practical understanding of how these policies could impact everything from acquisition costs and pricing models to patient outcomes and inventory reliability. The conversation also highlights regulatory and legislative responses, and what pharmacies can do now to prepare. From strategic sourcing to investing in automation and domestic partnerships, David offers clear-eyed guidance for navigating today's trade turbulence.

It is expected that the need for long-term care at home services will double in the next fifty years - putting an even larger strain on caregivers and the healthcare workforce. On this episode of Marketing Vitals, VP of GRX Marketing, Kelly Bailey, is joined by trusted partners Paul Shelton from LTC @ Home and Susan Barrett from HealNow to discuss shifting to a patient engagement model. Tune in to learn how together we can improve your cash flow today and enhance patient outcomes tomorrow. If you have any questions or interested in working together, please contact us! Paul Shelton at pshelton@pharmacomplete.com, Susan Barratt at susan@healnow.io, and Kelly Bailey – kelly.bailey@grxmarketing.com.

in the premiere episode of The Executive Dose, host Stephen Beckman—CEO of YARAL Pharma-sits down with Nicholas Hart, CEO of IBSA USA, for a timely and insightful conversation on the forces shaping the pharmaceutical industry in 2025. From supply chain disruption and regulatory pressure to innovation in both branded and generic sectors, these two leaders explore how today's pharma CEOs are steering through uncertainty and preparing for the next wave of transformation.